8 Best Pharma Stocks To Buy In India

When it comes to the most loved sector of the Indian stock market we have pharma stocks, between the time period 2009 and 2016 pharma stocks gave us a return of 30% CARG. So we had to make an article on the best pharma stocks to buy in India.

Due to the outbreak of the current pandemic, it is a very wise decision to invest in pharma stocks, even if you are a beginner or a pro in investing in the stock market you should consider these 8 best pharma stocks before making your next investment.

8 Best Pharma Stocks To Buy In India

Best Pharma Stocks

Best Pharma Stocks To Buy In India

Advertisements

Sun Pharmaceuticals Industries Limited

Best Pharma Stocks: Sun Pharmaceuticals Industries Limited (Sun Pharma Inds.) is a pharmaceutical company. The total valuation (market value) of the company is ₹2,21,501 crore. The price of one share of the company is ₹908.80 in the BSE market and ₹908.30 in the NSE market. Sun Pharmaceuticals Industries Limited was established in the year 1993.

As per the report provided by the company, the total income for the last year stood at Rs.14,042.85 crore and the total sales stood at Rs.12,531.93 crore. The company’s net profit stood at Rs 3,211.14 crore. Sun Pharmaceuticals Industries Limited has paid a tax of Rs -337.06 crore in the current year.

Dr. Reddys Laboratories Limited

Best Pharma Stocks: Dr. Reddys Laboratories Limited (Dr. Reddys Lab) is a pharmaceuticals sector company. The total valuation (market value) of the company is ₹68,598 crore. The price of one share of the company is ₹4,045.20 in the BSE market and ₹4,044.00 in the NSE market. Dr. Reddys Laboratories Limited was established in the year 1984.

Advertisements

As per the report provided by the company, the total income for the last year stood at Rs 12,593.6 crore and the total sales were Rs 11,850.4 crore. The company’s net profit stood at Rs 2,937.7 crore. Dr. Reddy’s Laboratories Limited has paid a tax of -476.9 crores in the current year.

Divis Laboratories Limited

Best Pharma Stocks: Divis Laboratories Limited (Divis Lab) is a pharmaceutical company. The total valuation (market value) of the company is ₹1,19,683 crore. The price of one share of the company is ₹ 4,424.35 in the BSE market and ₹ 4,421.25 in the NSE market. The company was established in the year 1990.

Advertisements

As per the report provided by the company, the total income for the last year stood at Rs 5,500.43 crore and the total sales stood at Rs 5,310.57 crore. The company’s net profit stood at Rs 1,372.71 crore. Divis Laboratories Limited has paid a tax of Rs-445.97 crore in the current year.

Best Pharma Stocks To Buy In India
Why Invest In Pharma

Cipla Limited

Best Pharma Stocks: Cipla Limited (Cipla) is a pharmaceutical company. The total valuation (market value) of the company is ₹78,809 crore. The price of one share of the company is ₹ 960.30 in the BSE market and ₹ 960.60 in the NSE market. The company was established in the year 1935.

As per the report provided by the company, the total income for the last year stood at Rs 13,572.91 crore and the total sales stood at Rs 12,659.15 crore. The company’s net profit stood at Rs 2,318.17 crore. Cipla Limited has paid a tax of Rs.664.98 crore in the current year.

Advertisements

Biocon Limited

Best Pharma Stocks: Biocon Limited (Biocon) is a company in the biotechnology sector. The total valuation (market value) of the company is ₹44,740 crore. The price of one share of the company is ₹371.40 in the BSE market and ₹371.65 in the NSE market. The company was established in the year 1978.

As per the report provided by the company, the total income for the last year stood at Rs 2,388.8 crore and the total sales stood at Rs 2,184.2 crore. The company’s net profit stood at Rs 440.9 crore. Biocon Limited has paid a tax of Rs-90.7 crore in the current year.

Aurobindo Pharma Limited

Best Pharma Stocks: Aurobindo Pharma Limited is a pharmaceutical company. The total valuation (market value) of the company is ₹37,637 crore. The price of one share of the company is ₹634.00 in the BSE market today and ₹633.50 in the NSE market today. The company was established in the year 1986.

Advertisements

As per the report provided by the company, the total income for the last year stood at Rs.13,669.85 crore and the total sales stood at Rs.13,266.48 crore. The company’s net profit stood at Rs 1,872.74 crore. Aurobindo Pharma Limited has paid a tax of Rs-378.7 crore in the current year.

Best Pharma Stocks
Pharma Stocks

Lupin Limited

Best Pharma Stocks: Lupin Limited (Lupin) is a pharmaceutical company. The total valuation (market value) of the company is ₹33,712 crore. The price of one share of the company is ₹736.00 in the BSE market and ₹736.35 in the NSE market. The company was established in the year 1983.

As per the report provided by the company, the total income for the last year stood at Rs.11,500.85 crore and the total sales stood at Rs.11,025.66 crore. The company’s net profit stood at Rs 727.55 crore. Lupin Limited has paid a tax of Rs.385.92 crore in the current year.

Abbott India Limited

Best Pharma Stocks: Abbott India Limited is a pharmaceutical company. The total valuation (market value) of the company is ₹36,215 crore. The price of one share of the company is ₹16,960.00 in the BSE market and ₹16,940.45 in the NSE market. Abbott India Limited was established in the year 1944.

As per the report provided by the company, the total income for the last year stood at Rs.4,207.796 crore and the total sales stood at Rs.4,093.144 crore. The company’s net profit stood at Rs 592.933 crore. Abbott India Limited has paid a tax of -229.171 crores in the current year.

Advertisements

ALSO, READ:

DISCLAIMER

The information and material contained in these blog are subject to change without prior notice. Investments in debentures, equity shares etc, are not obligations of or guaranteed by TeknikalRaman.com, and are subject to investment risks.

The information contained in this website, graphics, links, including text or other items are provided on an ‘as is’, ‘as available’ basis. TeknikalRaman.com does not warrant the adequacy, accuracy, or completeness of this information and material and expressly disclaims liability for errors or omissions in this information and material. In no event will TeknikalRaman.com be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages.

Sharing Is Caring:

Related Posts

Leave a Comment